Examination of the colons showed that Siglec-XII–expressing mice presented significantly increased tumor burden over controls (Figure 4, B and C), and the bases of the tumors were typically associated with immune cell infiltrates (arrows, compare Figure 4, D and E). The gene discussed is SIGLEC12; the disease is neoplasm.